Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease
Terminated
Romark Laboratories L.C.
Phase 2
2005-08-01
The primary objective of this study is to evaluate the efficacy and safety of nitazoxanide
compared to a placebo in reducing the signs and symptoms of mild to moderate active Crohn's
disease in adults.
Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Infection
Completed
Baylor College of Medicine
Phase 3
2004-01-01
The purpose of this study is for compassionate use of nitazoxanide in the treatment of
diarrheal disease due to Clostridium difficile infection when the patient has failed previous
treatment with metronidazole or vancomycin.
Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Infection
Completed
Daniel M. Musher MD
Phase 3
2004-01-01
The purpose of this study is for compassionate use of nitazoxanide in the treatment of
diarrheal disease due to Clostridium difficile infection when the patient has failed previous
treatment with metronidazole or vancomycin.
Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Infection
Completed
VA Medical Center, Houston
Phase 3
2004-01-01
The purpose of this study is for compassionate use of nitazoxanide in the treatment of
diarrheal disease due to Clostridium difficile infection when the patient has failed previous
treatment with metronidazole or vancomycin.
Study of Nitazoxanide in the Treatment of Clostridium Difficile-associated Disease
Terminated
Romark Laboratories L.C.
Phase 3
2006-12-01
The primary objective of the study is to demonstrate non-inferiority of nitazoxanide compared
to vancomycin in resolving symptoms of Clostridium difficile-associated disease (CDAD).
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
